First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors-Reference-Cited by-同舟云学术

First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors

Published:2020-09-28 Issue:1 Volume:11 Page:80-91
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Yap Timothy A.^ORCID,Tan David S.P.^ORCID,Terbuch Angelika,Caldwell Reece,Guo Christina^ORCID,Goh Boon Cher,Heong Valerie^ORCID,Haris Noor R. Md.,Bashir Saira,Drew Yvette^ORCID,Hong David S.^ORCID,Meric-Bernstam Funda,Wilkinson Gary^ORCID,Hreiki Joseph,Wengner Antje M.,Bladt Friedhelm,Schlicker Andreas,Ludwig Matthias,Zhou Yinghui,Liu Li,Bordia Sonal^ORCID,Plummer Ruth^ORCID,Lagkadinou Eleni,de Bono Johann S.

Funder

Cancer Prevention and Research Institute of Texas

Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy

Center for Clinical and Translational Sciences

MD Anderson Cancer Center

Singapore Ministry of Health's National Medical Research Council

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer;Journal of Experimental & Clinical Cancer Research;2024-08-21

2. Chemo-Phosphoproteomic Profiling with ATR Inhibitors Berzosertib and Gartisertib Uncovers New Biomarkers and DNA Damage Response Regulators;Molecular & Cellular Proteomics;2024-08

3. Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer;2024-07-12

4. New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives;Journal of Medicinal Chemistry;2024-07-02

5. Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms;British Journal of Cancer;2024-06-22